Company Filing History:
Years Active: 2017-2020
Title: Eunbi Yi: Innovator in Viral Research
Introduction
Eunbi Yi is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of viral research, particularly in methods that enhance virus production and infection. Her innovative approaches have the potential to impact vaccine development and treatment strategies for viral diseases.
Latest Patents
Eunbi Yi holds 2 patents that focus on advancing our understanding of virus production. Her first patent, titled "Method for promoting virus infection and increasing virus production, by using cell line having lost BST2 gene functions," describes a method that utilizes a cell line lacking the Bst2 gene to enhance virus production and infection rates. This invention aims to improve the yields of target viruses and antigen proteins, which can be crucial for vaccine preparation.
The second patent, "Cell strain having increased virus production ability and production method therefor," details a cell line with an enhanced capacity for virus production due to the loss of the Bst-2 gene function. This mutant cell line demonstrates superior virus production capabilities compared to wild-type cell lines, making it a valuable tool for vaccine research and development.
Career Highlights
Eunbi Yi is currently associated with Immunomax Co., Ltd., where she continues her research in viral production and infection methods. Her work is instrumental in advancing the field and providing new avenues for vaccine development.
Collaborations
Eunbi collaborates with several professionals in her field, including Se-Ho Park and Se-ho Park, who contribute to her research endeavors. Their combined expertise enhances the quality and impact of their work.
Conclusion
Eunbi Yi's innovative research and patents in viral production highlight her significant role in the scientific community. Her contributions are paving the way for advancements in vaccine development and treatment of viral diseases.